Skip to main content
Figure 2 | Molecular Medicine

Figure 2

From: Hematopoietic CC-Chemokine Receptor 2 (CCR2) Competent Cells Are Protective for the Cognitive Impairments and Amyloid Pathology in a Transgenic Mouse Model of Alzheimer’s Disease

Figure 2

Aβ plaque formation remains similar in the brain of APPSwe/PS1 and APPSwe/PS1/CCR2−/− mice transplanted with WT (GFP) or CCR2−/− BMCs. Hemibrain sections of 6-month-old APPSwe/PS1 and APPSwe/PS1/CCR2−/− mice transplanted with GFP or CCR2−/− BMC (A–E) were immunostained for Aβ. Stereological analysis was performed to determine plaque density (F–G), plaque size (H–I) and the percentage area occupied by plaques (J–K) for each group in the hippocampus (F, H, J) and cerebral cortex (G, I, K). Transplantation of GFP or CCR2−/− cells in APPSwe/PS1 and APPSwe/PS1/CCR2−/− mice had no major effect on plaque formation. Results are expressed as the mean ± SEM; n = 6−15; *P < 0.05, **P < 0.01 and ***P < 0.001 versus APPSwe/PS1; #P < 0.05 versus APPSwe/PS1/CCR2−/−. One-way ANOVA was performed using the Bonferroni or Tamhane post hoc test. Scale bar 500 µm. ■, APPSwe/PS1; , GFP → APPSwe/PS1;, CCR2−/− → APPSwe/PS1;, APPSwe/PS1/CCR2−/−; , GFP → APPSwe/PS1/CCR2−/−.

Back to article page